Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Evaluating the Impact of Emergency Maternity Housing

17 juni 2022 bijgewerkt door: William Evans, University of Notre Dame

Evaluating the Impact of Emergency Maternity Housing on Mother and Child Well-being, Housing, and Employment

Moms will call and agencies will determine if she is eligible based on basic criteria. If she is eligible, the agency will send her an intake application link to complete, which includes a consent form. After completing the survey, if she is still eligible, she will be placed on a waitlist for services. When a bed becomes available in an individual agency, the agency will call two moms at the top of the waitlist, conduct in-person interviews to confirm eligibility and good fit. They will use a computer to randomly assign one to treatment and one to control. Agency will let moms know of their status and will allow the treatment mom to move in. Moms in treatment and control will be surveyed approximately one year post the mother's reported due date of the child.

Studie Overzicht

Toestand

Werving

Conditie

Interventie / Behandeling

Gedetailleerde beschrijving

The process begins when an expectant month calls a home seeking housing. The maternity home caseworker will ask basic screening questions to determine eligibility. Those found ineligible are referred elsewhere. If the mom is eligible, the caseworker will send her a link to an online application asking a variety of questions surrounding her current housing and employment, health and mental health, other children, criminal justice involvement, etc. The application will include a brief consent form asking for permission to use her information. She will have the option of consenting or not. When she submits her response, the caseworker will be able to review her answers. If there are any answers that would make the mom ineligible at this point, the caseworker will call her and refer her to other local services. If she is still a good fit, the caseworker will call her and let her know that she is eligible but that they don't have any open beds, and that she will be put on a waitlist for the next available bed.

When a bed becomes available, a caseworker will call the top two moms on the waitlist and schedule a time for an in-person interview. They will conduct both interviews to confirm eligibility. After the interview, caseworkers might convene at the home to discuss whether the moms are good fits for group living (for example, the mothers are sometimes unwilling to abide by house rules and they might indicate hesitancy during an interview). If one is not a good fit, the caseworker will let her know she is ineligible and bring in the next mom on the list for an interview. Once two moms are found eligible, the caseworkers will put their names into a separate survey form, which on the backend will randomly assign one to treatment and one to control. The caseworker will call each mom back and let her know if they are going to be able to help her based on her randomization status. Control moms will be referred to other local services. Treatment moms will schedule a time to move in. Both consented and unconsented moms will be randomized the same - having the same odds of receiving services.

Note that three of the five homes will utilize the procedure above. The fourth and fifth homes will complete the same process up to the waitlist stage. Once a bed is available, the caseworker will call the top two moms on the waitlist to confirm they are still interested, then they will randomize them and let them know their status. Only the treatment mom will be brought in for an interview since this home is confident they will be able to determine eligibility based off of the phone and survey application screen and only need the interview to determine services for moms who will actually move into the home.

All moms will complete a follow up survey about one year after the estimated birth of the child (as reported as the due date at baseline).

Studietype

Ingrijpend

Inschrijving (Verwacht)

1048

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

  • Naam: William Evans, PhD
  • Telefoonnummer: 5746317039
  • E-mail: wevans1@nd.edu

Studie Contact Back-up

  • Naam: Vivian Crumlish, MEd
  • Telefoonnummer: 5746311669
  • E-mail: vcrumlis@nd.edu

Studie Locaties

  • Verenigde Staten
    • Indiana
      • Notre Dame, Indiana, Verenigde Staten, 46556
        • Werving
        • University of Notre Dame
        • Contact:
          • William Evans, PhD
          • Telefoonnummer: 574-631-7039
          • E-mail: wevans1@nd.edu
        • Contact:
          • Vivian Crumlish, MEd
          • Telefoonnummer: 574-631-1669
          • E-mail: vcrumlis@nd.edu

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar en ouder (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Ja

Geslachten die in aanmerking komen voor studie

Vrouw

Beschrijving

Inclusion Criteria:

  • Each home has their own eligibility criteria. The main three criteria common across homes are that a woman must be at least 18 years old, experiencing housing instability, and pregnant. No home has an income standard because, by definition, applicants are in a precarious housing situation so most women are low-income. Each home does have slightly different eligibility criteria. For example, some homes allow other children to come with her into the home, while other homes do not. Some homes require a background check and might allow a woman to enter the home anyway depending on the prior offense.

Exclusion Criteria:

  • Women who are not pregnant, men, pregnant women under 18, some homes exclude mothers who have other children currently in their care

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Ondersteunende zorg
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Geen tussenkomst: Controle
Verwezen naar andere beschikbare diensten in de gemeenschap
Experimenteel: Maternity Home Bed
Receives a bed in the maternity home, wrap-around services, etc.
Ander: Maternity Housing
Receives a bed in the maternity home, wrap-around services, etc.
Andere namen:
  • Emergency Maternity Housing

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Difference in rates of self-reported taking baby to term between treatment and control groups
Tijdsspanne: 1 year after approximate due date of baby
The research team will use self-reported rates of taking the baby to term between treatment and control groups
1 year after approximate due date of baby
Difference in rates of self-reported retaining custody of baby between treatment and control groups
Tijdsspanne: 1 year after approximate due date of baby
The research team will use survey data to quantify the impact of receiving a bed in the maternity home on self-reported retaining custody of the baby
1 year after approximate due date of baby
Difference in rates of self-reported loneliness and depression between treatment and control groups
Tijdsspanne: 1 year after approximate due date of baby
The research team will use survey data to quantify the impact of receiving a bed in the maternity home on self-reported loneliness and depression levels.
1 year after approximate due date of baby
Difference in rates of self-reported life satisfaction between treatment and control groups
Tijdsspanne: 1 year after approximate due date of baby
The research team will use survey data to quantify the impact of receiving a bed in the maternity home on self-reported life satisfaction
1 year after approximate due date of baby
Difference in rates of self-reported sense of self-efficacy between treatment and control groups
Tijdsspanne: 1 year after approximate due date of baby
The research team will use survey data to quantify the impact of receiving a bed in the maternity home on self-reported sense of self-efficacy
1 year after approximate due date of baby
Difference in housing stability between treatment and control groups
Tijdsspanne: 1 year after approximate due date of baby
The research team will use self-reported independent living status and whether the mom has a mortgage or lease in her own name at the time of follow to quantify the impact of receiving a bed in the maternity home on housing stability.
1 year after approximate due date of baby
Difference in rates of continuum of care utilization between treatment and control groups
Tijdsspanne: 1 year after approximate due date of baby
The research team will use mother's interactions with other local service agencies involved in the locality's continuum of care system to quantify the impact of receiving a bed in the maternity home on continuum of care interactions.
1 year after approximate due date of baby
Difference in employment rates between treatment and control groups
Tijdsspanne: 1 year after approximate due date of baby
The research team will use survey data to quantify the impact of receiving a bed in the maternity home on self-reported employment.
1 year after approximate due date of baby
Difference in safety-net utilization rates between treatment and control groups
Tijdsspanne: 1 year after approximate due date of baby
The research team will use survey data to quantify the impact of receiving a bed in the maternity home on self-reported amount of welfare received, for example TANF, WIC, SNAP, etc.
1 year after approximate due date of baby
Difference in education rates between treatment and control groups
Tijdsspanne: 1 year after approximate due date of baby
The research team will use survey data to quantify the impact of receiving a bed in the maternity home on self-reported education level.
1 year after approximate due date of baby

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Difference in housing stability between treatment and control groups
Tijdsspanne: 1 year after approximate due date of baby
The research team will explore using information from Infutor Data Solutions to also capture address changes and will compare these findings with the self-reported information about housing. Infutor data will only be an exploratory outcome.
1 year after approximate due date of baby

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Sponsor

University of Notre Dame

Medewerkers

Bethlehem House
In My Shoes
Our Lady's Inn, USA
Aid for Women
Maggie's Place, USA

Onderzoekers

  • Hoofdonderzoeker: Adrienne Sabety, PhD, University of Notre Dame
  • Hoofdonderzoeker: William Evans, PhD, University of Notre Dame
  • Hoofdonderzoeker: Jessica Brown, PhD, University of South Carolina

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

30 mei 2022

Primaire voltooiing (Verwacht)

1 december 2025

Studie voltooiing (Verwacht)

1 december 2025

Studieregistratiedata

Eerst ingediend

29 mei 2022

Eerst ingediend dat voldeed aan de QC-criteria

17 juni 2022

Eerst geplaatst (Werkelijk)

23 juni 2022

Updates van studierecords

Laatste update geplaatst (Werkelijk)

23 juni 2022

Laatste update ingediend die voldeed aan QC-criteria

17 juni 2022

Laatst geverifieerd

1 mei 2022

Meer informatie

Termen gerelateerd aan deze studie

Trefwoorden

Aanvullende relevante MeSH-voorwaarden

Andere studie-ID-nummers

  • 22-04-7182

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

JA

Beschrijving IPD-plan

We plan to create a de-identified dataset of participant data, which we will make available for other researchers. This dataset will contain the data necessary to replicate the analysis detailed in publications resulting from the study. We will only share data in a manner consistent with data sharing agreements which we establish with data providers. These data sharing agreements are still in process, so while we plan to share de-identified data at this time, we will only do so if our data sharing agreements allow it.

IPD-tijdsbestek voor delen

We will make data available when we release a publication resulting from the study. There will not be an end date for when data will be available.

IPD-toegangscriteria voor delen

We will make our dataset available to the general public by posting it on the website for the Inter-University Consortium for Political and Social Research (ICPSR).

IPD delen Ondersteunend informatietype

  • LEERPROTOCOOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • MVO

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren